OCEANSIDE, CA--(Marketwired - May 18, 2015) - Therapeutic Solutions International, Inc. (OTC PINK: TSOI) announced today the availability of our flagship product ProJuvenol™.

ProJuvenol™ and T-Rx™ can now be purchased via our newly opened e-commerce site www.youcanordernow.com, or by calling our toll free number at 877-602-0806. We will be announcing the availability of Vital Female™ shortly.

Tim Dixon, CEO, stated, "We are very excited to bring to market our first product, ProJuvenol™ as well as T-Rx™. As announced previously we are offering a 10% discount and free shipping (in the continental United States) on orders placed by May 31, 2015. Vital Female may also be ordered and receive the discount throughout the month and will be shipped when in stock"

ProJuvenol™ is a powerful synergistic blend of complex anti-aging ingredients inspired by nature to help promote cellular rejuvenation and healthy functionality for everyday living. Based upon pterostilbene, one of nature's unique and intelligent antioxidants/anti-inflammatories, ProJuvenol includes a scientifically valid blend of interactive ingredients with anti-aging and cellular protective properties to help support optimal healthy blood sugar levels and provides benefits to sharpen mental alertness and physical well-being.

T-Rx™ for men is formulated to assist in increasing your testosterone levels and keeping it high. The result is a significant increase in testosterone levels, which assist in adding lean muscle mass, bone density, increased energy and the reduction of fat.

Vital™ for women is designed to increase energy, increase bone density, reduce fat and improve muscle tone. Additionally Vital will optimize hormone levels, increase libido, and decrease symptoms of stress and anxiety.

About Therapeutic Solutions International, Inc.
The Company's corporate website is www.therapeuticsolutionsint.com. Our new products can be viewed on www.projuvenol.com and products can be ordered at www.youcanordernow.com. These Supplement products have not been evaluated by the United States Food and Drug Administration. These products are not intended to diagnose, treat, cure or prevent any diseases.

Safe Harbor Statement
This release contains forward-looking statements that are based upon current expectations or beliefs, as well as a number of assumptions about future events. Although we believe that the expectations reflected in the forward-looking statements and the assumptions upon which they are based are reasonable, we can give no assurance that such expectations and assumptions will prove to have been correct. Forward-looking statements are generally identifiable by the use of words like "may," "will," "should," "could," "expect," "anticipate," "estimate," "believe," "intend," or "project" or the negative of these words or other variations on these words or comparable terminology. The reader is cautioned not to put undue reliance on these forward-looking statements, as these statements are subject to numerous risk factors as set forth in our SEC filings. To the extent that statements in this press release are not strictly historical, including statements as to product launch timing, revenue projections, business strategy, outlook, objectives, future milestones, plans, intentions, goals, future collaboration agreements, or otherwise as to future events, such statements are forward-looking, and are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. The forward-looking statements contained in this release are subject to certain risks and uncertainties that could cause actual results to differ materially from the statements made.

Contact Information:

Therapeutic Solutions International, Inc.